External Advisory Committee
In order to remain competitive in the industry, at the School of Chemical Engineering we have formed an External Advisory Committee, also known as the EAC. The EAC advises us about educational programs and research directions in chemical engineering, industrial chemistry, food science and technology from an external perspective. They let us know how the outside world sees us, what they need and how we can deliver it – all in order to stay ahead of the game.
How does it work?
The process is simple and works both ways. The External Advisory Committee could be briefed on a specific issue within the School, and they advise us on what to do (from an external perspective. Alternately, the EAC may raise an issue or identify an opportunity that they think the School should address. There are no hard and fast rules, and all outcomes are aimed at strengthening the relationship between the School and industry.
What makes up the EAC
The EAC consists of a Chair and up to nine members. These members come from a range of industry groups and professional disciplines. Members of the EAC are required to commit to a two year involvement to ensure that their input is strategic and long term. They get together at least twice a year, but are flexible depending on what is happening in the industry or at the School.
Short to medium term challenges identified
At present there are a number of short to medium term challenges that have been pinpointed by the EAC. These are:
- Improving the student learning experience and subsequently the CATEI
- Improving the HSC intake in terms of quality and quantity
- Strengthening the School’s engagement with industry in the region
- Strengthening School research output, particularly increasing research funding from industry
External Advisory Committee members 2017 - 2019
Daniel Kenny joined OncoSil Medical in January 2015 with almost 30 years’ experience in Global Pharmaceutical and Medical Device industry.
Daniel is an accomplished and proven biopharmaceutical business leader and in his career he has developed and successfully driven business with industry leaders such as Roche, Allergan and Baxter working in Australia, EMEA and the US.
Prior to joining OncoSil Medical, Daniel held the position of Chief Commercial Officer at ABIVAX a Paris based global biopharmaceutical company specialising in the development of novel vaccines and anti-virals.
At Baxter Daniel served as Global Franchise Head Vaccines overseeing all Franchise Operations. Before this role, Daniel served as Vice President Baxter BioScience, EMEA with responsibility for all marketing and key business programmes in support of regional sales exceeding $1.9bio.
Daniel also served with Roche as Global LifeCycle Leader for Roaccutance, a product generating sales in excess of CHF 1.1 bio (2002) assuming responsibility for all global strategic marketing and business development activities. Prior to this role he was International Medical Manager and Medical Science and Safety Team leader responsible for post NDA clinical development strategy and critical issue work ups for regulatory authorities.
Daniel completed over 10 years in clinical research in the fields of Ophthalmology with the Royal Australian College of Ophthalmologists and the University of Sydney and HIV/AIDS research at the University of New South Wales, Sydney, Australia prior to joining the pharmaceutical industry.
Daniel is a graduate in Physics from the University of New South Wales and has completed Executive business studies at both INSEAD and London Business School. He is a graduate of the Australian Institute of Physics and is a member of the Australian Institute of Company Directors.
Chris is currently responsible for overseeing the development and commercialisation of new membranes and membrane systems, and improvements to existing UF and MF membrane technologies for Evoqua.
Initially starting as a project engineer with the Australian membrane technology company Memtec Ltd in 1997, Chris has transitioned with the business through a variety of roles. Chris developed skills in engineering in a manufacturing environment after working for 3 years on projects designing and implementing new capital equipment for USFilter. Chris then spent 2 years in process engineering and water treatment, evaluating the performance of membranes and optimising membrane process operations for Veolia. After a further 2 years in project management, Chris then held the position of Manufacturing Engineering Manager for 6 years with Siemens Water Technologies. Combining research with business development, Chris moved into the role of R&D Commercialisation Manager in 2010. Following the acquisition of the business by AEA Investors in 2013 and the subsequent creation of a new water business – Evoqua Water Technologies, Chris became R&D Manager in 2016 and Process Technology Manager in 2019.
Chris holds a Bachelor of Chemical Engineering (Hons) from UNSW and an MBA (Executive) from the Australian Graduate School of Management. Chris is a Member of the Institution of Engineers Australia (EA) and an Associate Member of the Institution of Chemical Engineers (IChemE).
Balbir Singh is a General Manager for Technical Operations at 3M Australia. He is responsible for the deployment of R&D, Application Development, Regulatory and Quality strategies across Health care, Safety, Security, Electrical & Energy, Industrial and Consumer market segments.
Over the last 28 years, Balbir has developed expertise in Innovation, Technology Roadmap development and Commercialisation processes. Since 2006 he has pursued interests in the health care and consumer retail area where he has been responsible for developing Technology Roadmaps on locally developed ideas. Balbir completed his Health Science degree and post graduate qualifications from RMIT and MGSM respectively. His professional interests include technology commercialisation, strategy implementation and technology roadmap development and diversification.
BOC, a member of the Linde Group is actively pursuing opportunities in the energy and transportation industries and Alex is responsible for developing the LNG and Hydrogen (Renewable) markets and businesses for BOC in the South Pacific. This includes the production, and the entire supply chain infrastructure supplying directly to customers.
Prior to joining BOC, Alex had 20 years experience in the oil and gas industries with Shell in Australia and overseas in senior management roles in oil refining Supply, Economics and Operations management. He also worked for Elgas where he was responsible for commissioning and the ongoing business management of the greenfield Sydney Underground LPG Cavern and Import/Export facility, the largest in the Southern hemisphere.
Daniel Mullette joined Arnott’s in July 2014 as Program Manager – Chocolate, developing the latest Tim Tam innovations. In 2015 he moved to lead ingredient & process science programs for Arnott’s, as Senior Program Manager for the New Technology team. After successful development of technical product and process capabilities across multiple categories, including guiding development of Arnott’s first patent in more than 30 years, he added Product Development responsibilities in January 2018 as R&D Director – Savoury & New Technology, leading all short and long term product development for brands such as Shapes and Cracker Chips. In March 2019 he took on overall responsibility for all research and development efforts for Campbell Arnott’s in Australia & New Zealand. As R&D Director ANZ, Daniel is currently responsible for both the delivery of technology, innovation and supply chain support for culinary, product, process, packaging, regulatory and nutrition.
Before coming to Arnott’s, Daniel spent 8 years at Unilever across a variety of product commercialisation roles in process engineering, technical project leadership and technical management; supporting product development, factory scale-up and marketing activation with Unilever Australasia across Hair, Skin & Deodorant categories.
Prior to Unilever, Daniel also spent 6 years in product development at Memcor Australia (now Evoqua Water Technologies). As a development chemist, he researched multiple types of membrane materials, manufacturing process and post-treatment techniques, filing 7 patents on 3 new materials and 4 processes.
Daniel earned his bachelor’s degree in Industrial Chemistry from the University of New South Wales, Sydney Australia.
Fiona is Managing Director of the Australian Institute of Food Science and Technology (AIFST). She is an experienced Corporate and Regulatory Affairs professional who has been involved in leading and facilitating change and developing management strategies across a portfolio of food policy and regulation matters in global FMCG and NGO environments.
Fiona has more than 30 years’ experience in the food industry in the areas of dairy, seafood, cereal based foods, smallgoods, tea, simmer sauces and pastes, ingredients and infant formula. Fiona has previously worked for a large FMCG company in the role of Group Quality and Corporate Affairs Manager. In this role she was responsible for providing leadership across Australia and New Zealand in the areas of food policy and regulation; consumer affairs and communication; issues and crisis management and food quality and safety.
Fiona is a Fellow of the Australian Institute of Food Science and Technology. Fiona is currently serving as a Non-Executive Director and Deputy Chair of Healthy Kids. Fiona is a member of Allergy and Anaphylaxis Australia; an Associate Member of the Allergen Bureau and a member of the Australian Institute of Company Directors.
Fiona holds a Bachelor of Applied Science (Food Technology) from the University of Queensland and a Masters of Nutrition Management from the University of Wollongong.